FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Oncology Analytics is proud to announce that it has ranked 278th overall and 18th in the healthcare category in its first year of eligibility to be included in the prestigious Inc. 500|5000 ranking of America’s fastest growing private companies (http://www.inc.com/inc5000).
Oncology Analytics attributes its rapid growth to its unique ability to address complex clinical issues in real-time with treating physicians. This is accomplished by use of OA’s proprietary MetisTM system, supported by a peer to peer review process conducted by board certified specialists in hematology/oncology. These in-house physicians are backed by an extensive board of clinical advisors, Distinguished Academic Advisors, and board certified oncology PharmD’s.
Oncology Analytics’ clinical capabilities are supported by a patented software process that eliminates the financial incentives to utilize more costly treatments.
According to Dr. Marc Fishman, the founder of Oncology Analytics, “It is unfortunate that the current payment systems reward the use of more costly treatments. While cancer care is often very costly, frequently more cost-effective treatments are available. However, if a physician makes $5 on a treatment costing $100, but can make $500 on a treatment costing $10,000, it is not surprising that costs are higher than necessary. Oncology Analytics recognizes and addresses the economics of cancer care, as well as ensuring that all patients receive the highest quality care in accordance with nationally recognized guidelines and the scientific literature.”
About ONCOLOGY ANALYTICS
Oncology Analytics (OA) is a URAC-accredited provider of oncology management services to payers and clinical decision support expertise to providers focused on improving clinical efficacy, reducing toxicity and assuring reasonable costs. Founded in 2009, OA creates value through its proprietary software, database of over 1,300 treatment protocols, a patented reimbursement system, and clinically rigorous decision support. OA provides physicians the freedom to practice without restrictive pathways, patients the peace of mind that they are receiving evidence-based care and payers the best value for dollar spent. For more information on OA please go to www.oncologyanalytics.com or call 888-916-2616.
